Severe Refractory Vasoplegic Shock Syndrome After OPCABG: Our Experience and Review of Literature
Preprint
- 14 November 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: Vasoplegic shock syndrome(VSS) after an off-pump coronary artery bypass graft (OPCABG) is an extremely rare condition. Inotropic support is usually the first-line therapy though it can precipitate several complications or be ineffective. We report the first case of severe refractory VSS after OPCABG successfully treated with hydroxycobalamin. Methods: A 77-year-old gentleman underwent OPCABG for three vessels coronary artery disease. Preoperative LV ejection fraction was 28%, and the patient before surgery started sacubi-tril/valsartan titrated, then, to the highest dose. Surgery was uneventful and, by the end of the procedure, TEE showed improved biventricular contractility. Results: The patient was transferred to the ICU without inotropic support but he developed soon hypotension. TEE ruled out pericardial tamponade and confirmed fair contractility. Norepineph-rine was titrated to a medium-high dose, vasopressin was started and a Swan-Ganz catheter was placed. SVR was 480 dyn·s·cm−5. Despite aggressive pharmacologic treatment (including Methylprednisolone and Methylene blue), no improvements were noticed. 10 g of hydroxycobalamin were administered. One hour later hemodynamic status re-assessment showed SVR > 800 dyn·s·cm−5. Afterward, vasopressors were gradually reduced. Conclusions: Our case demonstrated the importance of adequate early treatment in VSS after OPCABG. For the first time, hydroxycobalamin was effectively used to restore homeostasis.Keywords
All Related Versions
- Version 1, 2023-11-14, Preprints
- Published version: Journal of Clinical Medicine, 13 (1), 169.
This publication has 25 references indexed in Scilit:
- Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgeryHeart & Lung, 2021
- The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass VasoplegiaCardiovascular Drugs and Therapy, 2020
- Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanismsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2019
- Profound Vasoplegia During Sacubitril/Valsartan Treatment After Heart TransplantationCanadian Journal of Cardiology, 2018
- The Use of High-Dose Hydroxocobalamin for Vasoplegic SyndromeThe Annals of Thoracic Surgery, 2014
- Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery?European Journal of Cardio-Thoracic Surgery, 2008
- Cell Response to SurgeryArchives of Surgery, 2006
- Preoperative Methylene Blue Administration in Patients at High Risk for Vasoplegic Syndrome During Cardiac SurgeryThe Annals of Thoracic Surgery, 2005
- Vasoplegic syndrome after off-pump coronary artery bypass surgery.European Journal of Cardio-Thoracic Surgery, 2003
- Vasoplegic syndrome: A new dilemmaThe Journal of Thoracic and Cardiovascular Surgery, 1994